Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer

Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer

Ovarian cancer accounts for most deaths from gynecologic malignancies. Although more than 80% of patients respond to first-line standard of care, most of these responders present with recurrence and eventually succumb to carcinomatosis and chemotherapy-resistant disease. To improve patient survival,...

Full description

Bibliographic Details
Main Authors: Ayesha B. Alvero, Douglas Hanlon, Mary Pitruzzello, Renata Filler, Eve Robinson, Olga Sobolev, Roslyn Tedja, Alessandra Ventura, Marcus Bosenberg, Patrick Han, Richard L. Edelson, Gil Mor
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
ovarian cancer
immunotherapy
dc-based vaccine
transimmunization
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1758869

Internet

http://dx.doi.org/10.1080/2162402X.2020.1758869

Similar Items